Perenchies, France

Marilyne Bourotte

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Marilyne Bourotte

Introduction

Marilyne Bourotte is a distinguished inventor based in Perenchies, France, known for her significant contributions to pharmaceutical innovations. With five patents to her name, she has made remarkable strides in the field of therapeutics, particularly in the treatment of infectious diseases.

Latest Patents

Marilyne's latest patents reflect her dedication to addressing critical health challenges. One of her notable inventions involves compounds of Formula (I), which play a crucial role in therapy for conditions like mycobacterial infections and tuberculosis. Additionally, she has developed rifabutin treatment methods that include formulations of highly concentrated solutions and novel methods for treating bacterial infections effectively.

Career Highlights

Throughout her career, Marilyne has collaborated with leading organizations, including Bioversys AG and GlaxoSmithKline Intellectual Property Development Limited. Her work at these companies has enabled her to focus on groundbreaking research that tackles some of the most pressing health issues.

Collaborations

Marilyne has worked alongside notable colleagues such as Esther Porras De Francisco and Modesto Jesús Remuiñan-Blanco. These collaborations have fostered an environment of innovation and discovery, enhancing the development of their patents and inventions.

Conclusion

Marilyne Bourotte's journey as an inventor is marked by her commitment to advancing medical science. Her patents stand as a testament to her innovative spirit and her contribution to improving healthcare. With her continued efforts, she is sure to make a lasting impact in the field of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…